phenobarbital sodium molecular weight - An Overview
phenobarbital sodium molecular weight - An Overview
Blog Article
pentobarbital will reduce the extent or effect of eplerenone by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Insignificant/Significance Unidentified.
pentobarbital will lessen the level or effect of mavacamten by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Contraindicated.
Check Closely (1)pentobarbital will reduce the level or effect of buprenorphine subdermal implant by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Modify Therapy/Watch Intently. Monitor individuals already on buprenorphine subdermal implant who demand freshly-initiated therapy with CYP3A4 inducer for signs and symptoms of withdrawal. In case the dose of the concomitant CYP3A4 inducer cannot be minimized or discontinued, implant removing can be vital along with the patient should then be addressed with a buprenorphine dosage variety that permits dose adjustments.
pentobarbital will lower the level or effect of eletriptan by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Watch.
Phenytoin, sodium valproate, valproic acid: The effect of barbiturates around the metabolism of phenytoin appears for being variable. Some investigators report an accelerating effect, although others report no effect. As the effect of barbiturates to the metabolism of phenytoin just isn't predictable, phenytoin more info and barbiturate blood levels needs to be monitored much more regularly if these drugs are given concurrently.
5. Typical lethal degree, the upper finish with the vary incorporates those that acquired some supportive procedure.
pentobarbital will lessen the level or effect of triamcinolone acetonide injectable suspension by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Keep track of.
fentanyl transdermal and pentobarbital both raise sedation. Keep away from or Use Alternate Drug. Restrict use to patients for whom alternative treatment method choices are inadequate
pentobarbital will decrease the level or effect of montelukast by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Insignificant/Importance Mysterious.
pentobarbital will lower the extent or effect of estrogens conjugated artificial by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Monitor.
pentobarbital will minimize the level or effect of celecoxib by impacting hepatic enzyme CYP2C9/ten metabolism. Slight/Importance Unidentified.
pentobarbital will lower the level or effect of nimodipine by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Small/Importance Unidentified.
pentobarbital will reduce the level or effect of alosetron by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Slight/Significance Unidentified.
pentobarbital will decrease the extent or effect of carbamazepine by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Check.